Know All About COVID-19 Vaccine Status in India: let’s turn our attention towards the COVID-19 Vaccine. Let’s know all about COVID-19 Vaccine Status in India and around the world.

Know All About COVID-19 Vaccine Status in India

COVAXIN

India developed it’s first indigenous COVID-19 vaccine COVAXIN

COVAXIN is developed by

  • Hyderabad based Bharat Biotech (Bio-Safety Level 3)
  • Pune based National Institute of Virology (Bio-Safety Level 3) under Indian Council of Medical Research (ICMR)

What is Bio-safety Level?

A Bio-safety level (BSL), or Pathogen Protection level, is biocontainment precautions level which is required to isolate dangerous pathogens in an enclosed laboratory.The Bio-safety level or Pathogen Protection level is categorized into four level. These are P1,P2,P3,P4. Where P1 is the lowest level of  Bio-safety level and P4 is the highest level of Bio-safety level.

Type of Vaccine

COVAXIN is an inactivated Vaccine.

What is the Achievements?

  • The team accelerated its objective to complete the comprehensive pre-clinical studies.
  • The result of the studies show the promising, safe and effective immune responses.

What’s Next?

  • The approval of the Drug Controller General of India CDSCO (The Central Drugs Standard Control Organisation) and Ministry of Health & Family Welfare is granted permission for Phase one & Phase two Human clinical trials.
  • The vaccine will passe through cost-effective trails for commercial production before the final vaccine is made available for the patients.

ZyCoV-D

ZyCoV-D is the second vaccine made in India through indigenous effort.

ZyCoV-D is developed by

Ahmedabad-based Zydus Cadila Healthcare Ltd

What is the Achievements?

  • Zydus Cadila Healthcare Ltd claimed that the vaccine candidate did not show vector response.
  • The company also claimed that the vaccine has much-improved stability and lower cold chain requirements thus it will be easier for transportation of vaccine to remotest parts of the country.
  • Zydus Cadila also got an approval from the Drugs Controller General of India (DCGI) for human clinical trials of COVID-19 vaccine.

There are also some other companies like Pune based Serum Institute of India, New Delhi based Panacea biotech are in the leading race in COVID-19 vaccine formulation

The status of Vaccines around the world

Here are some major breakthroughs in recent times

  • USA based drug company Pfizer informed that they are in some positive developments.
  • Germany based biotech firm BioNTech also spurred positive immune responses in their trials.
  • Scientists of the University of Oxford already have achieved a breakthrough in vaccine (AZD1222) trails.
  • Chinese company Sinopharm claims about 100% antibody response in their vaccine trails.
  • Another Chinese company Sinovac Biotech’s COVID-19 vaccine is proved to be successful in clinical trials.

Apart from these, there are more than 100 Pharmaceutical companies are working in the developments of COVID-19 vaccines.

Related Articles

Print Friendly, PDF & Email
Share The Article
  •  
  •  
  •  
  •  
  •  
Categories: Articles

0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Open chat
1
Need Help? Chat with us
Hello?
How can we help you?